Intro VIGOLY

走进维奥

公司简介

维奥兰羽生物科技（北京）有限公司   

       维奥兰羽生物科技（北京）有限公司是以色列维奥兰羽生物制药科技有限公司在华合资公司，专注于兽医生物制品科研、开发和生产。公司目前已建成两个生产基地：山东滨州家禽冻干疫苗和灭活疫苗生产基地、北京细胞冷冻疫苗生产基地。生产基地拥有符合GMP标准的现代化的厂房设施、疫苗生产车间和进口装备，建立了成熟稳定的欧洲及以色列国生产疫苗的SOP标准作业程序体系，拥有先进的生产工艺以及严格的质量控制和质量保证系统。维奥兰羽生物科技（北京）有限公司除了致力于家禽生物疫苗的开发和研究，同时和国内外同行企业、科研院所建立了广泛的联系以获得先进的技术和资讯支持。

       维奥兰羽生物科技（北京）有限公司致力于打造生物领域高科技的合资品牌－维奥兰羽，全心为用户提供优质的产品和技术服务。

Company’s   Profile

Vigoly Bio. Tech. (Beijing) Co. Ltd is a joint venture in China set up by Vigoly Biological Laboratories Israel Ltd, engaged in research and development, production, quality control and marketing of poultry vaccines. 

There are two production bases under Vigoly namely Shandong Binzhou poultry freeze-dried and inactivated vaccine production base and Beijing frozen cells vaccine production base. Its activities are carried out under control of the standard operation procedures and requirement of GMP applied in Europe. 

The company’s research and production lines are placed under the constant supervision of quality control laboratories, where its products receive approval and are inspected by the Authorities of Agriculture. In addition to its activities, the company focalizes in the marketing and distribution of veterinary products from its own production, and from leading international and local companies in the veterinary field in Israel and all over the world.

Vigoly is committed to enhancing the health, well-being and performance of animals. Our strengths is in treatment, disease prevention and eradication of infectious disease among poultry (such as: NDV, IBD, Marek, Avian Influenza, IB, FP, ILT, Salmonella, CRD, AE, TE, HE, Fawl Cholera, EDS, etc.) in large farms, as well as clinical treatment with regard to preparation of vaccination programs and biosecurity plans.